Presentation is loading. Please wait.

Presentation is loading. Please wait.

Improving the Accuracy of Mesothelioma Diagnosis in China

Published byMadison Bond Modified over 5 years ago

Similar presentations

Presentation on theme: "Improving the Accuracy of Mesothelioma Diagnosis in China"— Presentation transcript:

1 Improving the Accuracy of Mesothelioma Diagnosis in China
Zhenying Guo, MD, Michele Carbone, MD, PhD, Xing Zhang, PhD, Dan Su, MD, PhD, Wenyong Sun, MD, Jianlin Lou, PhD, Zhibin Gao, MD, Dichu Shao, MD, Junqiang Chen, MD, Gu Zhang, BS, Jinlin Hu, BS, Kaiyan Chen, MD, Fang Wang, MD, Harvey I. Pass, MD, Herbert Yu, MD, PhD, Andrea Napolitano, MD, PhD, Haining Yang, MD, PhD, Weimin Mao, MD  Journal of Thoracic Oncology  Volume 12, Issue 4, Pages (April 2017) DOI: /j.jtho Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 Immunohistochemistry results for epithelial malignant mesothelioma (MM) and lung adenocarcinoma. (Left column) Epithelial MM positive for calretinin, Wilms tumor 1 (WT1), D2-40, and CAM5.2 and negative for CD15 and thyroid transcription factor-1 (TTF-1). (Right column) Lung adenocarcinoma positive for CAM5.2, CD15, and TTF-1 and negative for calretinin, WT1, and D2-40. Original magnification of main portion of all slides, ×100; original magnification of insets at right lower corner of each slide, ×400. HE, hematoxylin and eosin. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

3 Figure 2 Immunohistochemistry results for biphasic malignant mesothelioma (MM) and carcinosarcoma of the kidney, with both sets of slides showing a clear cell component. (Left column) Biphasic MM positive for calretinin and D2-40 and negative for Wilms tumor 1 (WT1), CAM5.2, CD15, and thyroid transcription factor-1 (TTF-1). (Right column) Carcinosarcoma of the kidney positive for CD15 and paired box 8 (PAX-8); negative for calretinin, WT1, and D2-40; and negative/weakly positive for CAM5.2. Original magnification, ×400. HE, hematoxylin and eosin. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

4 Figure 3 Expression of BRCA1 associated protein 1 (BAP1) and INO80 in malignant mesothelioma (MM). (Top row) MM, epithelial type, showing negative nuclear staining for BAP1 and for Ino80. (Middle row) Biphasic MM showing homogeneous BAP1 and Ino80 nuclear staining. (Bottom row) Sarcomatoid MM showing focal nuclear staining for BAP1 and for Ino80. Original magnification, ×400. Arrows point at tumor cells showing nuclear staining. HE, hematoxylin and eosin. Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

5 Supplementary Figure 1 Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

6 Supplementary Figure 2 Journal of Thoracic Oncology  , DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Improving the Accuracy of Mesothelioma Diagnosis in China"

Similar presentations

High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh.

High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh.
Quiz Page April 2011 American Journal of Kidney Diseases

Quiz Page April 2011 American Journal of Kidney Diseases
Epidemiology of Environmental Exposure and Malignant Mesothelioma

Epidemiology of Environmental Exposure and Malignant Mesothelioma
BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas  Noémie Leblay,

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas  Noémie Leblay,
High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma  Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh.

High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma  Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met–Amplified Adenocarcinoma of the.

Response to Crizotinib/Erlotinib Combination in a Patient with a Primary EGFR-Mutant Adenocarcinoma and a Primary c-met–Amplified Adenocarcinoma of the.
SC17.02 Lung Cancer in China: Challenges and Perspectives

SC17.02 Lung Cancer in China: Challenges and Perspectives
Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non–Small Cell Lung Cancer  Chao Li, MD, PhD,

Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non–Small Cell Lung Cancer  Chao Li, MD, PhD,
Epidemiology of Environmental Exposure and Malignant Mesothelioma

Epidemiology of Environmental Exposure and Malignant Mesothelioma
Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 

Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 
Quiz Page October 2015 American Journal of Kidney Diseases

Quiz Page October 2015 American Journal of Kidney Diseases
Localized Malignant Pleural Mesothelioma: Report of Two Cases

Localized Malignant Pleural Mesothelioma: Report of Two Cases
A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,
Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas  Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas  Yiliang Zhang, MD, Rui Wang, MD, PhD, Yuan.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Sclerosing Pneumocytoma with Lymph Node Metastasis

Sclerosing Pneumocytoma with Lymph Node Metastasis
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma  Taylor M.
Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 

Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 

Similar presentations

Ads by Google